280 related articles for article (PubMed ID: 26741267)
1. Baicalin loaded in folate-PEG modified liposomes for enhanced stability and tumor targeting.
Chen Y; Minh LV; Liu J; Angelov B; Drechsler M; Garamus VM; Willumeit-Römer R; Zou A
Colloids Surf B Biointerfaces; 2016 Apr; 140():74-82. PubMed ID: 26741267
[TBL] [Abstract][Full Text] [Related]
2. Role of generation on folic acid-modified poly(amidoamine) dendrimers for targeted delivery of baicalin to cancer cells.
Lv T; Yu T; Fang Y; Zhang S; Jiang M; Zhang H; Zhang Y; Li Z; Chen H; Gao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():182-190. PubMed ID: 28415453
[TBL] [Abstract][Full Text] [Related]
3. Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging.
Ding N; Lu Y; Lee RJ; Yang C; Huang L; Liu J; Xiang G
Int J Nanomedicine; 2011; 6():2513-20. PubMed ID: 22072885
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome.
Yang G; Yang T; Zhang W; Lu M; Ma X; Xiang G
J Agric Food Chem; 2014 Mar; 62(10):2207-15. PubMed ID: 24528163
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of a novel lipophilic folate receptor targeting ligand.
Liu Y; Xu S; Teng L; Yung B; Zhu J; Ding H; Lee RJ
Anticancer Res; 2011 May; 31(5):1521-5. PubMed ID: 21617205
[TBL] [Abstract][Full Text] [Related]
6. Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting.
Ye P; Zhang W; Yang T; Lu Y; Lu M; Gai Y; Ma X; Xiang G
Int J Nanomedicine; 2014; 9():2167-78. PubMed ID: 24855354
[TBL] [Abstract][Full Text] [Related]
7. Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.
Wang H; Zhao P; Liang X; Gong X; Song T; Niu R; Chang J
Biomaterials; 2010 May; 31(14):4129-38. PubMed ID: 20163853
[TBL] [Abstract][Full Text] [Related]
8. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.
Liu MC; Liu L; Wang XR; Shuai WP; Hu Y; Han M; Gao JQ
Int J Nanomedicine; 2016; 11():1395-412. PubMed ID: 27110110
[TBL] [Abstract][Full Text] [Related]
9. Optimisation of Folate-Mediated Liposomal Encapsulated Arsenic Trioxide for Treating HPV-Positive Cervical Cancer Cells In Vitro.
Akhtar A; Ghali L; Wang SX; Bell C; Li D; Wen X
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31052347
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxel.
Li X; Tian X; Zhang J; Zhao X; Chen X; Jiang Y; Wang D; Pan W
Int J Nanomedicine; 2011; 6():1167-84. PubMed ID: 21852896
[TBL] [Abstract][Full Text] [Related]
11. Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomes.
Malhi SS; Budhiraja A; Arora S; Chaudhari KR; Nepali K; Kumar R; Sohi H; Murthy RS
Int J Pharm; 2012 Aug; 432(1-2):63-74. PubMed ID: 22531856
[TBL] [Abstract][Full Text] [Related]
12. Relevance of folic acid/polymer ratio in targeted PEG-epirubicin conjugates.
Canal F; Vicent MJ; Pasut G; Schiavon O
J Control Release; 2010 Sep; 146(3):388-99. PubMed ID: 20621587
[TBL] [Abstract][Full Text] [Related]
13. [Preparation and properties of folate receptor-targeted cationic liposomes].
Yan Y; Qi XR
Yao Xue Xue Bao; 2008 Nov; 43(11):1134-9. PubMed ID: 19239034
[TBL] [Abstract][Full Text] [Related]
14. Microfluidic synthesis of PEG- and folate-conjugated liposomes for one-step formation of targeted stealth nanocarriers.
Hood RR; Shao C; Omiatek DM; Vreeland WN; DeVoe DL
Pharm Res; 2013 Jun; 30(6):1597-607. PubMed ID: 23386106
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
[TBL] [Abstract][Full Text] [Related]
16. Folate-targeting annonaceous acetogenins nanosuspensions: significantly enhanced antitumor efficacy in HeLa tumor-bearing mice.
Li H; Li Y; Ao H; Bi D; Han M; Guo Y; Wang X
Drug Deliv; 2018 Nov; 25(1):880-887. PubMed ID: 29608108
[TBL] [Abstract][Full Text] [Related]
17. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
[TBL] [Abstract][Full Text] [Related]
18. [Preparation and in vitro properties of folate receptor targeting docetaxel-loaded amphiphilic copolymer-modified liposomes].
Li X; Zhang J; Wang DK; Pan WS
Yao Xue Xue Bao; 2012 Sep; 47(9):1219-26. PubMed ID: 23227554
[TBL] [Abstract][Full Text] [Related]
19. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
[TBL] [Abstract][Full Text] [Related]
20. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma.
Li M; Shi K; Tang X; Wei J; Cun X; Chen X; Yu Q; Zhang Z; He Q
Eur J Pharm Sci; 2018 Nov; 124():240-248. PubMed ID: 30071282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
